Afuco™ Anti-S. epidermidis LTA ADCC Therapeutic Antibody (Pagibaximab), ADCC Enhanced
This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant Chimeric (human/mouse) antibody to S. epidermidis LTA. Pagibaximab is a chimeric monoclonal antibody for the prevention of staphylococcal sepsis in infants with low birth weight.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-TAB-H53 |
| Pricing | Inquiry |
| Host | Chimeric |
| Target | S. epidermidis LTA |
| Species Reactivity | S. epidermidis |
| Type | ADCC enhanced antibody |
| Applications | FuncS, IF, Neut, ELISA, FC, IP |
| Storage | Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles. |